• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products

home / publications / supplement / comparing-factor-use-bleed-rates-with-3-different-long-acting-recombinant-factor-viii-products
© 2024 MJH Life Sciences
AJMC®
All rights reserved.